The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...

This study highlights the successful development of a non-invasive biosensor for glucose monitoring, addressing many ...

In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the ...

Are you in the gray zone? Millions are living with prediabetes, unaware of the crucial difference between it and full-blown type 2 diabetes. Let’s ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...